SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Cardlytics, Inc. – ‘8-K’ for 3/10/20

On:  Tuesday, 3/10/20, at 4:17pm ET   ·   For:  3/10/20   ·   Accession #:  1666071-20-66   ·   File #:  1-38386

Previous ‘8-K’:  ‘8-K’ on / for 3/3/20   ·   Next:  ‘8-K’ on / for 5/11/20   ·   Latest:  ‘8-K’ on / for 3/18/24

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 3/10/20  Cardlytics, Inc.                  8-K:8       3/10/20   12:267K

Current Report   —   Form 8-K   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     28K 
12: R1          Document and Entity Information                     HTML     49K 
11: XML         IDEA XML File -- Filing Summary                      XML     12K 
10: XML         XBRL Instance -- cdlxform8-k202003_htm               XML     15K 
 9: EXCEL       IDEA Workbook of Financial Reports                  XLSX      6K 
 3: EX-101.CAL  XBRL Calculations -- cdlx-20200310_cal               XML      7K 
 4: EX-101.DEF  XBRL Definitions -- cdlx-20200310_def                XML     38K 
 5: EX-101.LAB  XBRL Labels -- cdlx-20200310_lab                     XML     79K 
 6: EX-101.PRE  XBRL Presentations -- cdlx-20200310_pre              XML     42K 
 2: EX-101.SCH  XBRL Schema -- cdlx-20200310                         XSD     16K 
 7: JSON        XBRL Instance as JSON Data -- MetaLinks               14±    21K 
 8: ZIP         XBRL Zipped Folder -- 0001666071-20-000066-xbrl      Zip     34K 


‘8-K’   —   Current Report


This is an HTML Document rendered as filed.  [ Alternative Formats ]



 iX:   C:   C:   C: 
  Document  
 i false i 0001666071 0001666071 2020-03-10 2020-03-10


 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
 
FORM  i 8-K
 
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):  i March 10, 2020
 
 
cardlytics_logoa22.jpg
 i CARDLYTICS, INC.
(Exact Name of Registrant as Specified in its Charter)
 
 i Delaware
 i 26-3039436
(State or other jurisdiction of
incorporation or organization)
(Commission
File Number)
(I.R.S. Employer
Identification No.)
 i 675 Ponce de Leon Avenue NE, Suite 6000
 i Atlanta
 i Georgia
 i 30308
(Address of principal executive offices, including zip code)
 
 i (888)
 i 798-5802
 
(Registrant's telephone, including area code)
 
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions:
 i 
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 i 
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 i 
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 i 
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Securities Exchange Act of 1934:
Title of each class
Trading symbol
Name of each exchange on which registered
 i Common Stock
 i CDLX
 i The Nasdaq Stock Market LLC
 Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
 i 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   i 

 





ITEM 8.01    OTHER EVENTS
On March 3, 2020, Cardlytics, Inc. entered into an a five-year agreement with U.S. Bank, National Association to begin a phased launch of the Cardlytics Direct program.









SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
 
Cardlytics, Inc.
 
 
 
 
Date:
By:
 
 
 
 
 
 
Chief Financial Officer
(Principal Financial and Accounting Officer)



Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘8-K’ Filing    Date    Other Filings
Filed on / For Period end:3/10/20SC 13G/A
3/3/2010-K,  4,  8-K,  S-8
 List all Filings 
Top
Filing Submission 0001666071-20-000066   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Thu., Mar. 28, 5:40:53.1pm ET